EPISODE · Feb 14, 2022 · 18 MIN
Semaglutide or Liraglutide for Weight Loss?
from CEimpact Podcast · host CEimpact
Weight gain can impact patient’s quality of life and put them at risk for health complications. While weight loss can be an important factor in a patient’s health, it is equally important that it is done safely and effectively. Listen in as host, Geoff Wall compares the safety and efficacy of semaglutide and liraglutide in weight loss. The GameChanger:Based on a recent Phase-3 study, semaglutide appears to be more effective in weight loss than liraglutide Semaglutide also appeared to have modest effects on decreasing systolic blood pressure, blood sugar, lipid concentrations, and serum insulin levelsGLP-1 agonists are expensive medications – patients should be made aware of the of the associated cost as a part of patient centered care Show Segments:00:00 – Introductions01:10 – GLP-1s Agonist (Semaglutide vs Liraglutide) in Weight Management10:00 – Change in Body Weight 12:02 – Secondary Outcomes – Blood Pressure, Blood Sugar, Lipid Concentrations, & Serum Insulin12:59 – Safety & Side Effects14:15 – Cost14:52 – The GameChanger17:20 – Closing RemarksLinks to Resources:Effects of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults with Overweight or Obesity Without DiabetesHow to Claim CE:CE is available for CEimpact members:· Click here to claim CPE Credit · Click here to claim CME Credit Need a membership?Join for CPE Credit Join for CME CreditContinuing Education Information:Learning Objectives: 1. Describe the inclusion and exclusion criteria of the STEP 8 study2. Discuss the outcomes of the STEP 8 studyDr. Wall is a member of the Janssen Speaker's Bureau. 0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-22-088-H01-PInitial release date: 02/14/22Expiration date: 02/14/2023Additional CPE & CME details can be found here"Follow CEimpact on Social Media:LinkedInInstagram
NOW PLAYING
Semaglutide or Liraglutide for Weight Loss?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m